吳 駿翃

Medicine & Life Sciences

1. ovatodiolide 100%
2. Neoplastic Stem Cells 90%
3. Catenins 89%
4. Neoplasms 82%
5. antrocin 68%
6. Antrodia 57%
7. Carcinogenesis 55%
8. Tumor Microenvironment 47%
9. Therapeutics 42%
10. Glioblastoma 41%
11. Colonic Neoplasms 40%
12. Neoplasm Metastasis 40%
13. Colorectal Neoplasms 39%
14. Down-Regulation 36%
15. Squamous Cell Carcinoma of Head and Neck 36%
16. Non-Small Cell Lung Carcinoma 36%
17. Radiotherapy 35%
18. pterostilbene 35%
19. MicroRNAs 35%
20. Breast Neoplasms 34%
21. Hepatocellular Carcinoma 34%
22. Lung Neoplasms 34%
23. Stem Cells 34%
24. destruxin B 33%
25. Chemoradiotherapy 33%
26. Proteins 30%
27. Colon 29%
28. Theranostic Nanomedicine 28%
29. ErbB Receptors 28%
30. Mucuna 27%
31. Spermatozoa 27%
32. Epithelial-Mesenchymal Transition 27%
33. Esophageal Squamous Cell Carcinoma 24%
34. Agammaglobulinaemia Tyrosine Kinase 24%
35. Apoptosis 24%
36. 4-acetylantroquinonol B 23%
37. Phenotype 23%
38. Cisplatin 23%
39. Tyrosine 23%
40. Pharmaceutical Preparations 23%
41. Computer Simulation 23%
42. In Vitro Techniques 23%
43. Drug Therapy 22%
44. Biomarkers 22%
45. Computational Biology 21%
46. STAT3 Transcription Factor 21%
47. Genes 21%
48. TOR Serine-Threonine Kinases 21%
49. Adenocarcinoma 21%
50. Glioma 21%